2 completed, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Withdrawn 1 |
Follow ziconotide: new trials by email Literature Review of ziconotide trials Research Report on ziconotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ziconotide as First-Line IDT Ziconotide 100 MCG(microgram)/ML Intrathecal Solution, Quantitative sensory testing, Serum markers: Interleukin-1, Interleukin-6, and tumor necrosis factor - Neuropathic Pain | Phase 4 | Completed | Albany Medical College | 13 | 2016-11-03 | 2021-01-12 |
| Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy Ziconotide, placebo - Painful Myelopathy, Painful Neuropathy | Phase 4 | Withdrawn | Aaron Boster | 2014-01-01 | 2018-09-18 | |
| Intrathecal Bolus Doses of Ziconotide Ziconotide - Peripheral Neuropathy | Phase 4 | Completed | University Hospital, Linkoeping | 26 | 2011-08-01 | 2014-12-30 |
Neuralgia (2) · Bronchiolitis Obliterans Syndrome (1) · Lymphoma, Follicular (1) · Neuropathy, Painful (1) · Peripheral Nervous System Diseases (1) · Wounds and Injuries (1)
Aaron Boster (1) · Albany Medical College (1) · University Hospital, Linkoeping (1)
United States (2) · Sweden (1)